Related Experiment Video
Updated: Aug 27, 2026
Analysis of Hematopoietic Stem Progenitor Cell Metabolism
Published on: November 9, 2019
Aplastic anemia: analysis of stromal cell function in long-term marrow cultures
L A Holmberg1, K Seidel, W Leisenring
1Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Abstract:
Marrow samples from 89 patients with aplastic anemia (AA) were evaluated for their ability to grow stromal layers in standard long-term marrow cultures (LTMCs). Results were highly variable: 6.8% failed to grow any stromal cells (group I); 42.5% either failed to grow to confluency or appeared to have a decreased number of adipocytes and/or macrophages (group II); and 52.8% appeared as normal confluent cultures with fibroblasts, adipocytes, and macrophages (group III). Analyses of patient data suggested that group I patients had a longer disease duration and poorer survival (P = .07). Enzyme-linked immunosorbent assay analysis of cytokine production was performed on 20 of the normal-appearing AA LTMCs and 12 LTMCs established from normal donors. Significant differences between the AA and control groups were apparent for macrophage inflammatory protein-1 alpha (MIP-1 alpha), interleukin-1 receptor antagonist (IL-1ra), granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), and leukemia-inhibitory factor (LIF). The most dramatic differences observed were elevated levels of MIP-1 alpha and GM-CSF and decreased levels of IL-1ra, particularly after IL-1 alpha stimulation. In contrast, IL-1 alpha stimulation of AA LTMCs produced levels of IL-6, LIF, and G-CSF comparable with those of controls. These data suggest that defects exist within the microenvironment of some AA marrows. Whether the majority of these defects are the cause or consequence of aplasia is not clear. However, we speculate that some of these abnormalities may contribute to the maintenance of the hypoplastic state and, in extreme cases, prevent engraftment of donor marrow.
Insights
Aplastic anemia (AA) bone marrow cultures show variable stromal growth, with some exhibiting altered cytokine profiles like elevated macrophage inflammatory protein-1 alpha (MIP-1 alpha) and granulocyte-macrophage colony-stimulating factor (GM-CSF). These microenvironmental defects may impact disease progression and marrow engraftment.
Area of Science:
- Hematology
- Stem Cell Biology
- Immunology
Background:
- Aplastic anemia (AA) is a rare but serious blood disorder.
- The bone marrow microenvironment plays a crucial role in hematopoiesis.
- Understanding the cellular and molecular characteristics of the AA bone marrow microenvironment is essential.
Purpose of the Study:
- To evaluate the in vitro growth of stromal layers from aplastic anemia (AA) bone marrow.
- To analyze cytokine production in AA long-term marrow cultures (LTMCs).
- To investigate potential microenvironmental defects in AA.
Main Methods:
- Long-term marrow cultures (LTMCs) were established from 89 AA patients and controls.
- Stromal layer growth, confluency, and cell types (fibroblasts, adipocytes, macrophages) were assessed.
- Cytokine levels (MIP-1 alpha, IL-1ra, GM-CSF, G-CSF, LIF, IL-6) were measured using ELISA in AA and control LTMCs.
Main Results:
- Stromal growth was variable in AA LTMCs: 6.8% failed, 42.5% showed poor growth/cell types, and 52.8% appeared normal.
- AA LTMCs showed significant differences in cytokine production compared to controls.
- Elevated MIP-1 alpha and GM-CSF, and decreased IL-1ra were observed in AA LTMCs, especially after IL-1 alpha stimulation.
Conclusions:
- Defects in the bone marrow microenvironment are present in some AA patients.
- Altered cytokine profiles, such as increased MIP-1 alpha and GM-CSF, may contribute to the hypoplastic state in AA.
- These microenvironmental abnormalities could potentially hinder donor marrow engraftment in severe AA cases.
